Mach7 Technologies (ASX:M7T) EBITDA: A$-16.75 Mil (TTM As of Dec. 2025)


ASX:M7T Mach7 Technologies Ltd ASX:M7T
35 GF Score
Price A$0.31
GF Value A$0.82
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Mach7 Technologies EBITDA?

Mach7 Technologies ASX:M7T +3.39% 35 EBITDA is A$-16.75 Mil as of Dec. 2025. GuruFocus rates ASX:M7T with a GF Score™ of 35/100 and a GF Value™ of A$0.82 (Possible Value Trap). The stock has 3 warning signs investors should review.

Mach7 Technologies's EBITDA for the six months ended in Dec. 2025 was A$-2.30 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$-16.75 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Mach7 Technologies was 50.00% per year. The lowest was -278.30% per year. And the median was -23.10% per year.

Mach7 Technologies's EBITDA per Share for the six months ended in Dec. 2025 was A$-0.01. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.07.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Mach7 Technologies was 83.20% per year. The lowest was -99.00% per year. And the median was -0.40% per year.

Mach7 Technologies  (ASX:M7T) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Mach7 Technologies EBITDA Related Terms


Mach7 Technologies EBITDA Historical Data

* Premium members only.

The historical data trend for Mach7 Technologies's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mach7 Technologies EBITDA Chart

Mach7 Technologies Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.83 2.80 -8.49 -15.09 -14.30

Mach7 Technologies Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.12 -12.96 0.15 -14.45 -2.30

ASX:M7T vs VEEV, BTSG, TEM: EBITDA Comparison

For the Health Information Services subindustry, Mach7 Technologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mach7 Technologies EV-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mach7 Technologies's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Mach7 Technologies's EV-to-EBITDA falls into.


ASX:M7T
35GF Score
Mach7 Technologies Ltd ASX:M7T
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Mach7 Technologies's EBITDA for the fiscal year that ended in Jun. 2025 is calculated as

Mach7 Technologies's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Jun. 2025, Mach7 Technologies's EBITDA was A$-14.30 Mil.

Mach7 Technologies's EBITDA for the quarter that ended in Dec. 2025 is calculated as

Mach7 Technologies's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2025, Mach7 Technologies's EBITDA was A$-2.30 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-16.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of A$-16.75 Mil mean?
Mach7 Technologies (ASX:M7T) has a EBITDA of A$-16.75 Mil as of Dec. 2025. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Mach7 Technologies.
Is Mach7 Technologies' EBITDA too high?
Mach7 Technologies' current EBITDA is A$-16.75 Mil. Overall, Mach7 Technologies has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mach7 Technologies' EBITDA compare to VEEV and BTSG?
Mach7 Technologies' EBITDA of A$-16.75 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Healthcare Providers & Services company?
A good EBITDA depends on the Healthcare Providers & Services industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Mach7 Technologies. Mach7 Technologies's current EBITDA is A$-16.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mach7 Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mach7 Technologies (ASX:M7T) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.82, compared to a current price of A$0.31 — trading 62.8% below its estimated fair value. The current EBITDA is A$-16.75 Mil. Mach7 Technologies' overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For Mach7 Technologies (ASX:M7T), the current EBITDA is A$-16.75 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mach7 Technologies (ASX:M7T) Overvalued in 2026?

Based on GuruFocus' analysis, Mach7 Technologies stock appears to be undervalued. The current stock price of A$0.31 is trading 62.8% below its estimated GF Value™ of A$0.82. GuruFocus considers Mach7 Technologies to be Possible Value Trap.

Key valuation signals for ASX:M7T:

  • EBITDA: A$-16.75 Mil
  • GF Value™: A$0.82 vs. price of A$0.31 (62.8% below fair value)
  • GF Score™: 35/100 with 3 warning signs

No single metric tells the full story. See the ASX:M7T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mach7 Technologies Business Description

Other Exchanges TDMMF:USA
Address 120 Kimball Avenue, Suite 210, South Burlington, VT, USA, 05403
Mach7 Technologies Ltd is a healthcare software company focused on enterprise imaging infrastructure. The company's vendor neutral platform enables health systems to manage, access, and exchange medical imaging data across departments, sites, and vendors. It serves across North America, Asia-Pacific, and the Middle East, with deployments ranging from academic medical centres to multi-site health networks. A substantial part of revenue is derived in the form of Subscription revenue. Geographically, it derives a majority of its revenue from North America.
35GF Score

Get the complete analysis for ASX:M7T

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.31
Price
A$0.82
GF Value